Literature DB >> 25575616

Reliability and Validity of the Before-School Functioning Scale in Children With ADHD.

Stephen V Faraone1, Paul G Hammerness2,3, Timothy E Wilens2,3.   

Abstract

OBJECTIVE: Children with ADHD frequently manifest behavioral difficulties in the morning prior to school. We sought to assess the reliability and validity of the Before-School Functioning Questionnaire (BSFQ) as a measure of morning behaviors impaired by ADHD.
METHOD: We used pre-treatment data from a randomized crossover study of 6- to 12-year-old participants comparing the methylphenidate transdermal delivery system (MTS) with a placebo transdermal system (PTS) for a total of 4 weeks.
RESULTS: The BSFQ investigator-rated scale shows very good internal homogeneity (Cronbach's α = .91), good test-retest reliability ( r = .60), good concurrent validity ( r range = .42-.86), and a strong treatment effect (effect size = -.93). The self-rated BSFQ showed lower levels of reliability and validity.
CONCLUSION: The investigator-rated BSFQ should be used in future trials of ADHD medications aimed at assessing efficacy in the morning before school.

Entities:  

Keywords:  ADHD; before school; children and adolescents; functioning; morning

Mesh:

Substances:

Year:  2015        PMID: 25575616     DOI: 10.1177/1087054714564623

Source DB:  PubMed          Journal:  J Atten Disord        ISSN: 1087-0547            Impact factor:   3.256


  5 in total

1.  Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder.

Authors:  Steven R Pliszka; Timothy E Wilens; Samantha Bostrom; Valerie K Arnold; Andrea Marraffino; Andrew J Cutler; Frank A López; Norberto J DeSousa; Floyd R Sallee; Bev Incledon; Jeffrey H Newcorn
Journal:  J Child Adolesc Psychopharmacol       Date:  2017-07-21       Impact factor: 2.576

2.  Early Morning Functional Impairments in Stimulant-Treated Children with Attention-Deficit/Hyperactivity Disorder Versus Controls: Impact on the Family.

Authors:  Stephen V Faraone; Russell J Schachar; Russell A Barkley; Rick Nullmeier; F Randy Sallee
Journal:  J Child Adolesc Psychopharmacol       Date:  2017-04-10       Impact factor: 2.576

3.  A Randomized, Double-Blind, Placebo-Controlled Study of HLD200, a Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder: An Evaluation of Safety and Efficacy Throughout the Day and Across Settings.

Authors:  Ann C Childress; Andrew J Cutler; Andrea Marraffino; Mary Ann McDonnell; John M Turnbow; Matthew Brams; Norberto J DeSousa; Bev Incledon; Floyd R Sallee; Sharon B Wigal
Journal:  J Child Adolesc Psychopharmacol       Date:  2019-08-29       Impact factor: 2.576

4.  Early Morning Functioning in Stimulant-Treated Children and Adolescents with Attention-Deficit/Hyperactivity Disorder, and its Impact on Caregivers.

Authors:  Floyd R Sallee
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-07-07       Impact factor: 2.576

5.  Clinically Meaningful Improvements in Early Morning and Late Afternoon/Evening Functional Impairment in Children with ADHD Treated with Delayed-Release and Extended-Release Methylphenidate.

Authors:  Timothy E Wilens; Stephen V Faraone; Paul G Hammerness; Steven R Pliszka; Cassandra L Uchida; Norberto J DeSousa; Floyd R Sallee; Bev Incledon; Jeffrey H Newcorn
Journal:  J Atten Disord       Date:  2021-06-04       Impact factor: 3.256

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.